In addition to these so-called 'recoding' editing events, many pre-mRNAs undergo A-to-I modification in untranslated exonic, and in non-coding intronic sequences.
The hydroxyl group reaction center added via Phase I modification in 4-hydroxy-PCB3 (Fig. 6, PCBI2) generates 4-PCB3-sulfate (PCBII3) and 4-PCB3-glucuronide (PCBII4).
Possible reasons for this unexpected finding are: i) a modification in the 3D structure of the channel subunit during a preparation step relocating the S1 S2 domain to the intracellular face of the membrane; or ii) the predicted transmembrane topology of the channel subunit does not correspond to its real conformation in vivo.
In class I modifications, the saddle was designed as 10 mm mesiodistally, 2.5 mm buccally, and 2.5 mm lingually from the center of the implant (Fig. 2).
Accordingly, we used multi-photon and second harmonic generation (SHG) imaging to investigate collagen I modifications around invasive DCIS lesions in our model.
At this level of analysis is practically impossible to separate 'causes' from 'consequences', i.e. modifications in gene expression that can play a role in the onset of the pathology and modifications that are induced by the fibrillation event.
The separation of four compound mixtures in 10 min by UHPLC may not seem to be impressive; however, the composition of the sample should be kept in mind, i.e. modifications in the structure of large oligonucleotide molecules are small.
Estimated GFR was calculated using a validated online equation provided by K/DOQI (Modification of Diet in Renal Disease (MDRD) study group and the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) group; http://www.kidney.org/professionals/kdoqi/gfr_calculator.cfm).org/professionals/kdoqi/gfr_calculator.cfm
In this article we introduce 10 new compounds, which are classified into two groups according to the attachment site of the phenylic substituent: group I compounds have modifications in the 5th position of the indole ring, group II in the 4th position of the indolo[2,1-b][1,3]benzoxazine indolo[2,1-b][1,3]benzoxazine
Let s i 1, …, s i k be binary or real-valued signals of k modifications in window i.
